Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
株式のランク
#4718
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
株価
$3.15
時価総額
$3.19B
変化（1日）
-0.05%
変化（1年）
-12.63%
国
CN
取引 Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
カテゴリー
Healthcare
Jiangsu Nhwa Pharmaceutical Co., Ltd.（002262）のEPS
June 2026 時点のEPS TTM: $0.16
Jiangsu Nhwa Pharmaceutical Co., Ltd.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は$0.16です。2023年末には、EPSは$0.15で、2022年のEPS$0.13と増加でした。
Jiangsu Nhwa Pharmaceutical Co., Ltd.のEPS履歴（2005から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $0.16 | 4.33% |
| 2024 | $0.15 | 6.39% |
| 2023 | $0.15 | 12.79% |
| 2022 | $0.13 | 3.78% |
| 2021 | $0.12 | 12.79% |
| 2020 | $0.11 | 17.11% |
| 2019 | $0.09 | 24.47% |
| 2018 | $0.08 | 26.21% |
| 2017 | $0.06 | 34.30% |
| 2016 | $0.04 | 11.50% |
| 2015 | $0.04 | 8.99% |
| 2014 | $0.04 | 23.57% |
| 2013 | $0.03 | 30.26% |
| 2012 | $0.02 | 20.00% |
| 2011 | $0.02 | 43.94% |
| 2010 | $0.01 | 43.48% |
| 2009 | $0.01 | 15.00% |
| 2008 | $0.01 | 42.86% |
| 2007 | $0.01 | 19.15% |
| 2006 | 0.00 | -16.07% |
| 2005 | $0.01 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 255.46% |
IN
|
